Research on the Entry Country - India - and the company's products for PAH (chosen company is United Therapeutics Corporation)
I need help researching for two things only because I did the segmenting, promotion, still doing the product, and done with distribution. So I need researching on the ff only:
(1) Pricing: What is the pricing strategy (not necessarily the price; but the pricing strategy (low price leader? High priced luxury leader? Value pricing? How will the pricing strategy support market entry? Competitive positioning?
(2) Estimate the annual costs of the marketing plan.
Develop a marketing plan (4P's )for the entry country. I chose India as the country I will enter to market United Therapeutics Corporation's four products. Include how the company would utilize the internet, telecommunications, social media (e.g., Facebook, Twitter) to facilitate its market penetration. What role would the proposed partner or in country agent/office play in any aspect of the marketing plan? Include in your plan:
What I have already:
Strategy One: United Therapeutics faces a number of options when it comes to exploring entry into a new foreign market and realizing their desire to become a more global player in the pharmaceutical market. One of these options would be for United Therapeutics to undergo a joint venture in India, working in partnership with a more established pharmaceutical company in order to handle the distribution and sales of their goods. Another potential entry strategy for United Therapeutics to explore is the possibility of direct export for their products into India. In this model, United Therapeutics would utilize independent distributors to supply PAH drugs within the Indian market.
Strategy Two: Both Sun Pharmaceuticals and Wockhardt are among the most well known names when it comes to pharmaceuticals in India. Although either of these two would make excellent future partners for United Therapeutics, their strengths do differ which, in turn, creates a difference in what they can provide or offer to UT (United Therapeutics).